Glaukos Corporation is a medical technology company that develops and commercializes innovative surgical devices and sustained-release drug therapies for the treatment of glaucoma and other eye diseases. The company's flagship product is the iStent family of micro-invasive glaucoma surgery (MIGS) devices, which are tiny implants designed to reduce intraocular pressure by creating a permanent opening in the eye's drainage system. Glaukos also develops sustained-release pharmaceutical products, including drug-eluting implants that deliver targeted therapy directly to the eye over extended periods.